AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
23:00
Oil prices fell by more than 7% on Monday, amid signals from Iran indicating openness to peace negotiations with the United States
22:57
Donald Trump announces the artists who will be honored at the Kennedy Center Honors gala
22:53
Likud, Benjamin Netanyahu’s party, calls for delaying the validation of the election, citing possible foreign interference in the vote
22:49
Piatra-Neamț City Hall is building a palliative care hospital with 40 beds, financed through European funds
22:46
USR and PNL call for an investigation into private flights to Mykonos and Nice / PSD wants the checks expanded
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
